Source: Eur Respir J 2013; 41: 1456-1458
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Bhanu Williams, Shiva Ramroop, Pooja Shah, Laura Anderson, Sreena Das, Anna Riddell, Sue Liebeschuetz, Robin Basu Roy, Maria O'Callaghan, Katherine Sloper, Jolanta Bernatoniene, Delane Shingadia, Beate Kampmann. Multidrug-resistant tuberculosis in UK children: presentation, management and outcome. Eur Respir J 2013; 41: 1456-1458

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy Source: International Congress 2016 – Update on drug-resistant tuberculosis Year: 2016 Management of multidrug-resistant tuberculosis and patients in retreatment Source: Eur Respir J 2005; 25: 928-936 Year: 2005 Multidrug-resistant tuberculosis in children: evidence from global surveillance Source: Eur Respir J 2013; 42: 701-707 Year: 2013 Childhood tuberculosis in Israel: epidemiological trends and treatment outcomes, 1999–2010 Source: Eur Respir J 2013; 41: 1157-1162 Year: 2013 Predictors of treatment outcome in multidrug-resistant tuberculosis in Portugal Source: Eur Respir J 2013; 42: 1747-1749 Year: 2013 Psychiatric issues during the treatment of the patients with multidrug-resistant tuberculosis Source: Annual Congress 2005 - Resistant and multidrug resistant tuberculosis Year: 2005 Immunological response in HIV-associated tuberculosis and the implications of HIV in the search for a tuberculosis vaccine Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news? Year: 2007 Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology Year: 2016 Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015 Extensively drug-resistant tuberculosis: early access to bedaquiline for a UK patient Source: Eur Respir J 2014; 43: 292-294 Year: 2004 Study of prevalence of drug resistance in tuberculosis (TB) patients attending a tertiary care hospital at Mumbai Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis Year: 2016 PG2 Multidrug-resistant tuberculosis management in settings with a low tuberculosis incidence Source: Milan 2017 - Educational material Year: 2017 Treatment outcomes for multidrug-resistant tuberculosis (MDR-TB) patients in Africa Source: Annual Congress 2011 - Multidrug-resistant tuberculosis Year: 2011 The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Multidrug-resistant tuberculosis in pregnant women: Treatment and birth outcomes Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: epidemiology, diagnosis and treatment Source: Annual Congress 2008 - Infection year in review Year: 2008 Characterization of mycobacterium abscessus subtypes in Shanghai: The drug sensitivity, bacterial epidemicity and clinical manifestations Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016 Long-term treatment outcomes in multidrug-resistant tuberculosis (MDR-TB) Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis Year: 2007